Hedgehog Activation Regulates Human Osteoblastogenesis.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
14 07 2020
Historique:
received: 23 01 2020
revised: 12 05 2020
accepted: 13 05 2020
pubmed: 13 6 2020
medline: 3 6 2021
entrez: 13 6 2020
Statut: ppublish

Résumé

Two genetic diseases, Gorlin syndrome and McCune-Albright syndrome (MAS), show completely opposite symptoms in terms of bone mineral density and hedgehog (Hh) activity. In this study, we utilized human induced pluripotent stem cell (iPSC)-based models of the two diseases to understand the roles of Hh signaling in osteogenesis. Gorlin syndrome-derived iPSCs showed increased osteoblastogenesis and mineralization with Hh signaling activation and upregulation of a set of transcription factors in an osteogenic culture, compared with the isogenic control. MAS-specific iPSCs showed poor mineralization with low Hh signaling activity in the osteogenic culture; impaired osteoblastogenesis was restored to the normal level by treatment with an Hh signaling-activating small molecule. These data suggest that Hh signaling is a key controller for differentiation of osteoblasts from precursors. This study may pave a path to new drug therapies for genetic abnormalities in calcification caused by dysregulation of Hh signaling.

Identifiants

pubmed: 32531191
pii: S2213-6711(20)30180-6
doi: 10.1016/j.stemcr.2020.05.008
pmc: PMC7363748
pii:
doi:

Substances chimiques

Chromogranins 0
Hedgehog Proteins 0
Transcription Factors 0
GNAS protein, human EC 3.6.1.-
GTP-Binding Protein alpha Subunits, Gs EC 3.6.5.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-139

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Dermatol Clin. 1995 Jan;13(1):113-25
pubmed: 7712637
Trends Cell Biol. 2002 Dec;12(12):562-9
pubmed: 12495844
Development. 2006 Aug;133(16):3231-44
pubmed: 16854976
Int J Mol Med. 2006 Jan;17(1):171-5
pubmed: 16328026
J Clin Invest. 2012 Oct;122(10):3490-503
pubmed: 22945629
Cell Metab. 2010 Feb 3;11(2):136-46
pubmed: 20142101
J Biol Chem. 2008 Apr 4;283(14):9224-30
pubmed: 18250171
Genes Dev. 2001 Dec 1;15(23):3059-87
pubmed: 11731473
Biochem Biophys Res Commun. 2007 Jun 15;357(4):854-60
pubmed: 17451649
J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:19-24
pubmed: 18292352
Nat Med. 2013 Nov;19(11):1505-12
pubmed: 24076664
J Clin Invest. 2013 Aug;123(8):3409-19
pubmed: 23867625
Nat Rev Mol Cell Biol. 2013 Jul;14(7):416-29
pubmed: 23719536
Nat Rev Rheumatol. 2015 Sep;11(9):552-60
pubmed: 26077918
Sci Adv. 2017 May 12;3(5):e1602875
pubmed: 28508073
Science. 1997 Aug 22;277(5329):1109-13
pubmed: 9262482
Bone Res. 2018 Nov 20;6:33
pubmed: 30479847
Development. 2009 Dec;136(24):4177-85
pubmed: 19906844
Mol Cell Biol. 2010 Apr;30(8):1910-22
pubmed: 20154143
Nature. 2002 Aug 29;418(6901):979-83
pubmed: 12198547
Cell. 2000 Feb 18;100(4):423-34
pubmed: 10693759
Development. 2004 Mar;131(6):1309-18
pubmed: 14973297
J Biol Chem. 2010 Oct 1;285(40):31055-65
pubmed: 20650891
Dev Cell. 2008 May;14(5):689-99
pubmed: 18477452
J Biol Chem. 2006 Nov 24;281(47):35598-602
pubmed: 17035233
Development. 2008 Jan;135(2):237-47
pubmed: 18057099
Curr Osteoporos Rep. 2015 Jun;13(3):146-58
pubmed: 25851935
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E418-E427
pubmed: 29158412
PLoS One. 2017 Oct 31;12(10):e0186879
pubmed: 29088246
Cell Metab. 2010 Feb 3;11(2):147-60
pubmed: 20142102
N Engl J Med. 1991 Dec 12;325(24):1688-95
pubmed: 1944469
Stem Cell Reports. 2014 May 22;2(6):751-60
pubmed: 24936463
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1401-1408
pubmed: 30025894
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4726-30
pubmed: 1584809
J Cell Biol. 2002 Apr 15;157(2):303-14
pubmed: 11956231
Genes Dev. 1999 Aug 15;13(16):2072-86
pubmed: 10465785
Pediatr Int. 2014 Oct;56(5):667-74
pubmed: 25131638
Development. 1998 Dec;125(23):4767-76
pubmed: 9806925
Cell. 1997 May 30;89(5):755-64
pubmed: 9182763
N Engl J Med. 1960 May 5;262:908-12
pubmed: 13851319
Mol Endocrinol. 2004 May;18(5):1222-37
pubmed: 14976225
Dev Biol. 2007 May 15;305(2):460-9
pubmed: 17400206

Auteurs

Shoko Onodera (S)

Department of Biochemistry, Tokyo Dental College, Tokyo 101-0061, Japan; Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8656, Japan.

Akiko Saito (A)

Department of Biochemistry, Tokyo Dental College, Tokyo 101-0061, Japan.

Hironori Hojo (H)

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8656, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8655, Japan.

Takashi Nakamura (T)

Department of Biochemistry, Tokyo Dental College, Tokyo 101-0061, Japan.

Denise Zujur (D)

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8656, Japan.

Katsuhito Watanabe (K)

Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo 101-0061, Japan.

Nana Morita (N)

Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College, Chiba 272-8513, Japan.

Daigo Hasegawa (D)

Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo 101-0061, Japan.

Hideki Masaki (H)

Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Hiromitsu Nakauchi (H)

Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305-5461, USA.

Takeshi Nomura (T)

Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College, Chiba 272-8513, Japan.

Takahiko Shibahara (T)

Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo 101-0061, Japan.

Akira Yamaguchi (A)

Oral Health Science Center, Tokyo Dental College, Tokyo 101-0061, Japan.

Ung-Il Chung (UI)

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8656, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8655, Japan.

Toshifumi Azuma (T)

Department of Biochemistry, Tokyo Dental College, Tokyo 101-0061, Japan; Oral Health Science Center, Tokyo Dental College, Tokyo 101-0061, Japan. Electronic address: tazuma@tdc.ac.jp.

Shinsuke Ohba (S)

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8656, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8655, Japan; Department of Cell Biology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8521, Japan. Electronic address: s-ohba@nagasaki-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH